Eric Van Ganse, Manon Belhassen, PELyon, & Francois Gavini, Roche, explain how French national claims data can deliver critical value to clinical trials and patients registries
Chad Presher & Meridith Hyres, Biogen, explore how industry supply chains are preparing for Gene and Cell Therapy treatments
James L. Sherley, Asymmetrex, proposes that stem cell research development partnerships can play a crucial role in accelerating progress in gene therapy clinical trials
Brandon Early, Vice President Clinical Development, PRA Health Sciences, examines the path to develop patient-specific treatments
Keleni Micheal Tukia, Bristol-Myers Squibb, explores how advancements made in gene therapy is key in the ongoing fight against cancer
Michael Sydes, George Clinical, discusses the scientific breakthroughs for treating Chemotherapy Induced Nausea and Vomiting in cancer patients
CTA Editor Henry Kerali explores the topic of temperature excursions asking what constitutes a robust cold chain strategy
Dr Joachim Luithle, VP, Head Clinical Development Operations, Bayer, speaks to CTA’s Adeola Coker about risk management in clinical operations
Alessio Brunello, MSc, Neurology & Ophthalmology Analyst, GlobalData, explores the implications of Janssen’s decision to halt its Alzheimer’s disease clinical trial
Guillaume Trusz, Antonia Wadley & Peter Kamerman conclude their deep dive into the recent post-marketing studies for the HIV antiretroviral stavudine
Go Top
